China Market Forecast: IVF Sector Projected to Surpass $11 Billion as Subsidies Accelerate Adoption
Recent 2026 market reports forecast the Chinese In Vitro Fertilization (IVF) market to exceed $11.2 billion by 2033, growing at a robust CAGR of 7.7%. This surge is heavily driven by the ongoing nationwide rollout of government financial subsidies for fertility treatments, shifting societal attitudes, and rising maternal age. Demand for advanced procedures like ICSI and Preimplantation Genetic Testing (PGT) is hitting record highs in tier-1 cities.
Business Insight: China is rapidly transitioning from a high out-of-pocket market to a state-supported volume market. For equipment manufacturers and pharmaceutical companies exhibiting at CMTF, the strategy must pivot toward "economies of scale." Participating in public hospital volume-based procurement (VBP) and offering cost-efficient, high-throughput lab automation will be essential to capturing this explosive demographic growth.
【Keywords】: #ChinaIVFMarket #MarketForecast #FertilitySubsidies #APACGrowth
【Source】: GlobeNewswire / ResearchAndMarkets 2026 Industry Report (Feb 2026)
